(CH )CH(CH )), 28.32 (C(CH ) ), 30.79 (CH ᎐C(CH )CH),
(2S,4R)-2-tert-Butoxycarbonylamino-4,5-dimethylhexanoic
᎐
3
3
3
3
2
3
38.06 (NHCHCH2), 52.00 (NHCHCO2CH3), 52.22 (CO2CH3),
79.53 (C(CH ) ), 110.19 (CH ᎐C(CH )), 144.62 (CH ᎐C(CH )),
155.18 (OC(O)NH) and 173.30 (NHCHCO2CH3); HRMS
294.1684 (MNa, C14H25NO4Na requires 294.1681 (δ 0.8 ppm));
m/z (Electrospray-MS) 272 (26%) and 216 (100%).
Diastereoisomer 16b was isolated as a colourless oil.
Analytical HPLC tr = 22.49 min (95%); [α]D20 ϩ16.0 (c 0.60 in
CHCl3); νmax(film)/cmϪ1 3369 (s), 3073 (m), 2969 (s), 1747 (s),
1717 (s), 1617 (w), 1517 (s) and 893 (m); δH (500 MHz; CDCl3)
1.04 (3H, d, J 7, CH3CH), 1.44 (9H, s, C(CH3)3), 1.55 (1H,
acid and (2S,4S)-2-tert-butoxycarbonylamino-4,5-dimethyl-
hexanoic acid. Following the general procedure for methyl
ester saponification (2S,4R)-2-tert-butoxycarbonylamino-4,5-
dimethylhexanoic acid methyl ester (60 mg, 0.22 mmol) yielded
(2S,4R)-2-tert-butoxycarbonylamino-4,5-dimethylhexanoic
acid (52 mg, 91%) as a colourless oil and was used directly in
the subsequent reaction. Analytical HPLC tr = 20.65 min
(100%); m/z (Electrospray-MS) 260 (18%) and 204 (100%).
Following the general procedure for methyl ester saponific-
᎐
᎐
3
3
2
3
2
3
ation
(2S,4S)-2-tert-butoxycarbonylamino-4,5-dimethylhex-
m, CH ᎐C(CH )CH), 1.67 (3H, s, CH ᎐C(CH )), 1.91 (1H,
m, NHCHCH2A), 2.32 (1H, m, NHCHCH2B), 3.72 (3H, s,
CO2CH3), 4.26 (1H, m, NHCHCO2CH3), 4.75 (1H, d, J 1.5,
anoic acid methyl ester (32 mg, 0.12 mmol) yielded (2S,4S)-
2-tert-butoxycarbonylamino-4,5-dimethylhexanoic acid (30 mg,
100%) as a colourless oil and was used directly in the sub-
sequent reaction. Analytical HPLC tr = 20.45 min (100%); m/z
(Electrospray-MS) 260 (20%) and 204 (100%).
᎐
᎐
2
3
2
3
CH2A᎐C(CH )), 4.79 (1H, d, J 1.5, CH ᎐C(CH )) and 5.46
᎐
᎐
3
2B
3
(1H, br d, J 6, NH); δC (125 MHz; CDCl ) 18.51 (CH ᎐
᎐
2
3
C(CH3)), 20.14 (CH ᎐C(CH )CH(CH )), 28.31 (C(CH3)3),
᎐
2
3
3
30.55 (CH ᎐C(CH )CH), 37.64 (NHCHCH ), 52.17 (NHCH-
᎐
2
3
2
(2S,4R)-2-Amino-4,5-dimethylhexanoic acid hydrochloride
salt and (2S,4S)-2-amino-4,5-dimethylhexanoic acid hydro-
chloride salt. Following the general procedure of N-Boc
removal using 4 M HCl in dioxane, (2S,4R)-2-tert-butoxy-
carbonylamino-4,5-dimethylhexanoic acid (52 mg, 0.20 mmol)
yielded (2S,4R)-2-amino-4,5-dimethylhexanoic acid hydro-
chloride salt (39 mg, 100%) as a solid and was used directly
in the subsequent reaction; m/z (Electrospray-MS) 160 (76%)
and 142 (100%).
Following the general procedure of N-Boc removal using
4 M HCl in dioxane, (2S,4S)-2-tert-butoxycarbonylamino-4,5-
dimethylhexanoic acid (32 mg, 0.12 mmol) yielded (2S,4S)-2-
amino-4,5-dimethylhexanoic acid hydrochloride salt (24 mg,
100%) as a solid and was used directly in the subsequent
reaction; m/z (Electrospray-MS) 160 (80%) and 142 (100%).
CO CH ), 52.22 (CO CH ), 79.74 (C(CH ) ), 111.27 (CH ᎐
᎐
2
2
3
2
3
3
3
C(CH )), 147.94 (CH ᎐C(CH )), 155.36 (OC(O)NH) and
᎐
3
2
3
173.83 (NHCHCO2CH3); HRMS 294.1673 (MNa, C14H25-
NO4Na requires 294.1681 (δ 2.9 ppm)); m/z (Electrospray-MS)
272 (73%) and 216 (100%).
Compound 16b was converted into the corresponding N-
acetyl derivative, which exhibited a signal at δ 111.27 in the
13C NMR spectrum , while the signal for the N-acetyl derivative
of 16a (prepared as a mixture with the N-acetyl derivative
of 16b) was at δ 110.2. These shifts compare very well with
shifts of δ 111.1 and 110.1 reported for the tentatively assigned
syn- and anti-N-acetyl analogues, respectively.15
(2S,4R)-2-tert-Butoxycarbonylamino-4,5-dimethylhexanoic acid
methyl ester 17a and (2S,4S)-2-tert-butoxycarbonylamino-4,5-
dimethylhexanoic acid methyl ester 17b
(2S,4R)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-4,5-di-
methylhexanoic acid 5a and (2S,4S)-2-(9H-fluoren-9-ylmethoxy-
carbonylamino)-4,5-dimethylhexanoic acid 5b
Following the general procedure for alkene hydrogenation,
the first eluted diastereoisomer of (2S,4R)-2-tert-butoxy-
carbonylamino-4,5-dimethylhex-5-enoic acid methyl ester 16a
(63 mg, 0.23 mmol) yielded (2S,4R)-2-tert-butoxycarb-
onylamino-4,5-dimethylhexanoic acid methyl ester 17a (60 mg,
95%) as a colourless oil. Analytical HPLC tr = 22.52 min (90%);
[α]D18 ϩ3.3 (c 0.60 in CH2Cl2); δH (500 MHz; CDCl3) 0.81 (3H,
d, J 7, (CH3)2ACH), 0.84 (3H, d, J 7, (CH3)2CHCH(CH3)),
0.87 (3H, d, J 7, (CH3)2BCH), 1.10 (1H, m, (CH3)2CH), 1.31
(1H, m, (CH3)2CHCH(CH3)), 1.43 (9H, s, C(CH3)3), 1.53
(1H, m, NHCHCH2A), 1.75 (1H, m, NHCHCH2B), 3.72 (3H, s,
CO2CH3), 4.26 (1H, br m, NHCHCO2CH3) and 4.96 (1H, br d,
J 7, NH); HRMS 296.1835 (MNa, C14H27NO4Na requires
296.1838 (δ 1.0 ppm)); m/z (Electrospray-MS) 274 (43%) and
218 (100%).
Following the general procedure for alkene hydrogenation,
the second eluted diastereoisomer of (2S,4S)-2-tert-butoxy-
carbonylamino-4,5-dimethylhex-5-enoic acid methyl ester 16b
(39 mg, 0.14 mmol) yielded (2S,4S)-2-tert-butoxycarbonyl-
amino-4,5-dimethylhexanoic acid methyl ester 17b (39 mg,
100%) as a colourless oil. Analytical HPLC tr = 22.49 min
(98%); [α]D18 ϩ 32.0 (c 0.10 in CH2Cl2); δH (500 MHz; CDCl3)
0.78 (3H, d, J 7, (CH3)2ACH), 0.84 (3H, d, J 7, (CH3)2-
CHCH(CH3)), 0.85 (3H, d, J 7, (CH3)2BCH), 1.37 (1H, m,
NHCHCH2A), 1.43 (9H, s, C(CH3)3), 1.52 (1H, m, (CH3)2CH-
CH(CH3)), 1.64 (1H, m, (CH3)2CH), 1.76 (1H, ddd, J 10, 7
and 6, NHCHCH2B), 3.72 (3H, s, CO2CH3), 4.29 (1H, br m,
NHCHCO2CH3) and 4.94 (1H, br d, J 7, NH); δC (125 MHz;
CDCl3) 15.16 (CH3)2CHCH(CH3)), 17.07 ((CH3)2ACH),
20.00 ((CH3)2BCH), 28.26 (C(CH3)3), 31.03 (CH3)2CH-
CH(CH3)), 34.66 (CH3)2CHCH(CH3)), 37.53 (NHCHCH2),
52.04 (NHCHCO2CH3), 52.12 (CO2CH3), 79.78 (C(CH3)3),
155.17 (OC(O)NH) and 173.89 (NHCHCO2CH3); HRMS
296.1830 (MNa, C14H27NO4Na requires 296.1838 (δ 2.7 ppm));
m/z (Electrospray-MS) 274 (40%) and 218 (100%).
Following the general procedure for Fmoc protection of
an amine, (2S,4R)-2-amino-4,5-dimethylhexanoic acid hydro-
chloride salt (39 mg, 0.20 mmol) gave on purification by flash
chromatography over silica gel, eluting with CHCl3–CH3OH
(100:0 to 95:5, v/v), (2S,4R)-2-(9H-fluoren-9-ylmethoxy-
carbonylamino)-4,5-dimethylhexanoic acid 5a (30 mg, 40%) as
an amorphous solid, mp 53–54 ЊC. Analytical HPLC tr = 23.46
min (100%); [α]D23 Ϫ10.4 (c 1.00 in CH3OH); δH (500 MHz;
CDCl3) 0.85 (9H, m, (CH3)2CHCH(CH3)), 1.34 (1H, m, (CH3)2-
CHCH(CH3)), 1.56 (1H, m, NHCHCH2A), 1.64 (1H, br
m, (CH3)2CHCH(CH3)), 1.89 (1H, m, NHCHCH2B), 4.21 (1H,
t, J 7, H-9Ј), 4.41 (3H, m, CH2O and NHCHCO2H), 5.09
(1H, br d, J 7, NH), 7.29 (2H, m, H-2Ј and H-7Ј), 7.39 (2H, m,
H-3Ј and H-6Ј), 7.56 (2H, m, H-1Ј and H-8Ј) and 7.76 (2H, d,
J 7, H-4Ј and H-5Ј); HRMS 404.1825 (MNa, C23H27NO4Na
requires 404.1838 (δ 3.2 ppm)); m/z (Electrospray-MS) 382
(100%).
Following the general procedure for Fmoc protection of
an amine, (2S,4S)-2-amino-4,5-dimethylhexanoic acid hydro-
chloride salt (24 mg, 0.12 mmol) gave on purification by flash
chromatography over silica gel, eluting with CHCl3–CH3OH
(100:0 to 95:5, v/v), (2S,4S)-2-(9H-fluoren-9-ylmethoxy-
carbonylamino)-4,5-dimethylhexanoic acid 5b (15 mg, 32%) as
an amorphous solid, mp 50–51 ЊC. Analytical HPLC tr = 23.23
min (100%); [α]D18 Ϫ12.8 (c 0.25 in CH3OH); δH (500 MHz;
CDCl3) 0.80 (3H, d, J 6.5, (CH3)2ACH), 0.89 (6H, d, J 6.5,
(CH3)2BCHCH(CH3)), 1.49 (1H, m, NHCHCH2A), 1.52 (1H, br
m, (CH3)2CHCH(CH3)), 1.66 (1H, br m, (CH3)2CHCH(CH3)),
1.91 (1H, br m, NHCHCH2B), 4.22 (1H, t, J 7, H-9Ј), 4.42
(3H, m, CH2O and NHCHCO2H), 5.13 (1H, br d, J 7, NH),
7.32 (2H, m, H-2Ј and H-7Ј), 7.39 (2H, m, H-3Ј and H-6Ј), 7.56
(2H, m, H-1Ј and H-8Ј) and 7.76 (2H, d, J 7, H-4Ј and H-5Ј);
δC (125 MHz; CDCl3) 15.08 ((CH3)2CHCH(CH3)), 16.94
J. Chem. Soc., Perkin Trans. 1, 2000, 4284–4292
4289